SEYFFERT, J.; STEFFES, W. Vitiligo following alemtuzumab therapy in multiple sclerosis: a demonstration of secondary autoimmunity. International Journal of Research in Dermatology, [S. l.], v. 5, n. 4, p. 882–884, 2019. DOI: 10.18203/issn.2455-4529.IntJResDermatol20194687. Disponível em: https://www.ijord.com/index.php/ijord/article/view/777. Acesso em: 12 oct. 2025.